TAK-831

DRUG4 trials

Sponsors

Neurocrine Biosciences

Conditions

Friedreich AtaxiaHealthyHealthy Volunteers

Phase 1

Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral Administration

CompletedNCT02716987

Neurocrine BiosciencesHealthy

Start: 2016-03-21End: 2016-08-30Updated: 2021-06-14

A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation

CompletedNCT03101293

Neurocrine BiosciencesHealthy Volunteers

Start: 2017-04-04End: 2017-05-26Updated: 2021-06-14

Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects

CompletedNCT03687684

Neurocrine BiosciencesHealthy Volunteers

Start: 2018-10-09End: 2019-06-19Updated: 2021-06-14

Phase 2

Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia

CompletedNCT03214588

Neurocrine BiosciencesFriedreich Ataxia

Start: 2017-11-08End: 2018-12-27Updated: 2021-06-14